Foresite Capital Management VI LLC Diversified Active

CIK: 0002013341 · Show all filings

Period: Q1 2025 (← Previous) (Next →)

Filing Date: May 15, 2025

Total Value ($000): $182,545 (100.0% shares, 0.0% debt)

Holdings (14)

CGON CG Oncology, Inc. 29.8%

Value ($000) $54,404 Shares 2,221,474 Est. Cost $34.21 Unrealized -17.8%

ALMS Alumis Inc 14.1%

Value ($000) $25,804 Shares 4,202,670 Est. Cost $10.02 Unrealized -42.0%

CNTA Centessa Pharmaceuticals Inc 9.9%

Value ($000) $18,024 Shares 1,253,379 Est. Cost $16.75 Unrealized —

— Rapt Therapeutics Inc 8.4%

Value ($000) $15,250 Shares 12,500,000 Est. Cost $1.58 Unrealized —

— Akero Therapeutics Inc 8.1%

Value ($000) $14,775 Shares 365,000 Est. Cost $27.82 Unrealized —

EWTX Edgewise Therapeutics Inc 7.1%

Value ($000) $12,870 Shares 585,000 Est. Cost $31.84 Unrealized -17.6%

BCAX Bicara Therapeutics Inc 6.8%

Value ($000) $12,379 Shares 950,000 Est. Cost $20.81 Unrealized -36.2%

GPCR Structure Therapeutics Inc 4.0%

Value ($000) $7,270 Shares 420,000 Est. Cost $27.12 Unrealized —

ALLO Allogene Therapeutics Inc 2.8%

Value ($000) $5,034 Shares 3,448,275 Est. Cost $2.47 Unrealized -23.6%

CRVS Corvus Pharmaceuticals Inc 2.8%

Value ($000) $5,028 Shares 1,581,233 Est. Cost $7.47 Unrealized -36.9%

CGEM Cullinan Therapeutics Inc 2.6%

Value ($000) $4,804 Shares 634,558 Est. Cost $14.37 Unrealized -33.2%

KYMR Kymera Therapeutics Inc 2.2%

Value ($000) $4,005 Shares 146,332 Est. Cost $45.17 Unrealized -19.3%

CASIF Casi Pharmaceuticals Inc 1.6%

Value ($000) $2,871 Shares 1,329,383 Est. Cost $4.74 Unrealized -48.4%

VRDN Viridian Therapeutics, Inc 0.0%

Value ($000) $27 Shares 1,974 Est. Cost $21.74 Unrealized -21.7%

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
CGON	CG Oncology, Inc.	2,221,474	$54,404	29.8%	$34.21	-17.8%	COM	156944100
ALMS	Alumis Inc	4,202,670	$25,804	14.1%	$10.02	-42.0%	COM	022307102
CNTA	Centessa Pharmaceuticals Inc	1,253,379	$18,024	9.9%	$16.75	—	SPONSORED ADS	152309100
—	Rapt Therapeutics Inc	12,500,000	$15,250	8.4%	$1.58	—	COM	75382E109
—	Akero Therapeutics Inc	365,000	$14,775	8.1%	$27.82	—	COM	00973Y108
EWTX	Edgewise Therapeutics Inc	585,000	$12,870	7.1%	$31.84	-17.6%	COM	28036F105
BCAX	Bicara Therapeutics Inc	950,000	$12,379	6.8%	$20.81	-36.2%	COM	055477103
GPCR	Structure Therapeutics Inc	420,000	$7,270	4.0%	$27.12	—	SPONSORED ADS	86366E106
ALLO	Allogene Therapeutics Inc	3,448,275	$5,034	2.8%	$2.47	-23.6%	COM	019770106
CRVS	Corvus Pharmaceuticals Inc	1,581,233	$5,028	2.8%	$7.47	-36.9%	COM	221015100
CGEM	Cullinan Therapeutics Inc	634,558	$4,804	2.6%	$14.37	-33.2%	COM	230031106
KYMR	Kymera Therapeutics Inc	146,332	$4,005	2.2%	$45.17	-19.3%	COM	501575104
CASIF	Casi Pharmaceuticals Inc	1,329,383	$2,871	1.6%	$4.74	-48.4%	ORD SHS	G1933S101
VRDN	Viridian Therapeutics, Inc	1,974	$27	0.0%	$21.74	-21.7%	COM	92790C104